Mallinckrodt Public Limited Company Stock Price and Value Analysis

Should you buy Mallinckrodt Public Limited Company stock? (NYSE:MNK). Let's see how it does in our automated value investing analysis system.

  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

MNK Free Cash Flow Trend

Hmm, we can't give any reliable projection for Mallinckrodt Public Limited Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for MNK
Free Cash Flow trendline for Mallinckrodt Public Limited Company

Inside the MNK Numbers

MNK Price
(Mallinckrodt Public Limited Company stock price per share)
[?] PE Ratio versus Sector 97% lower than other Healthcare stocks
[?] PE Ratio versus Industry 98% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield -0.41%
[?] Free Cash Flow Jitter 345%

Is Mallinckrodt Public Limited Company Stock on Sale?

Based on our analysis, we believe that you should not buy Mallinckrodt Public Limited Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MNK Stock?

Does Mallinckrodt Public Limited Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.